Gene
UGT1A1
UDP glucuronosyltransferase family 1 member A1
Explore in graph →CI-GENE-00037936HGNC:12530 ENSG00000241635 NCBI 54658 CIViC Cancer geneApproved
Curated evidence
Clinical evidence (2)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 26313268
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| UGT1A1 UGT1A1*281 | ||||||||
| Belinostat | Malignant NeoplasmALIAS | Predictive | A | Supports Adverse Response | 5 | accepted | EID1792The FDA approved package insert for Belinostat recommends dose adjustment for UGT1A1*28 allele homozygotes. PMID 26313268 · Goey et al., 2016 · Open in CIViC | civic |
| UGT1A1 UGT1A1*601 | ||||||||
| Belinostat | Malignant NeoplasmALIAS | Predictive | B | Supports Adverse Response | 4 | accepted | EID1795In a phase 1 trial belinostat (400-800mg/m2/24h) was administered to 25 patients in combination with cisplatin and etoposide. Endpoints were associations between genotype of UGT1A1 and pharmacokinetic… | |
Cohorts
Alteration frequency by cohort (1)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
- Source
- cBioPortal for Cancer Genomics (public studies)
- Dataset
- cBioPortal mutated genes by study
- Version
- cbioportal-2026-09-01
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- ODC Open Database License (ODC-ODbL) unless otherwise noted per study; attribution to the original studies required
- PMID
- 26091043
- Run
- ING-CBIOPORTAL-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Melanomas (TCGA, Cell 2015) skcm_tcga_pub_2015 | Cutaneous Melanoma | Ssm | 56 | 346 | 16.2% |
Literature
Linked publications (1)
25 per page, newest first.
- Source
- PubMed (NLM)
- Dataset
- PubMed E-utilities
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
· J Clin Pharmacol · 2016 · PMID 26313268 · validated civic_curation pubmed